Brentwood, United Kingdom

Stephen Dennis Pickett


Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Brentwood, GB (2003 - 2004)
  • West Malling, GB (2003 - 2006)

Company Filing History:


Years Active: 2003-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Stephen Dennis Pickett

Introduction

Stephen Dennis Pickett is a notable inventor based in Brentwood, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as therapeutic agents. With a total of 4 patents to his name, his work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Compounds and compositions as cathepsin inhibitors." This invention relates to novel selective cathepsin S inhibitors, including their pharmaceutically acceptable salts and N-oxides, along with their uses as therapeutic agents and the methods of their making. Another significant patent is "Substituted bicyclic heteroaryl compounds and their use as integrin antagonists," which showcases his innovative approach to drug development.

Career Highlights

Stephen has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma Limited and Aventis Pharmaceuticals Inc. His experience in these organizations has allowed him to refine his skills and contribute to various projects that advance medical research.

Collaborations

Stephen has collaborated with notable professionals in his field, including David Edward Clark and Paul Robert Eastwood. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Stephen Dennis Pickett's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of therapeutic agents that can improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…